Also Interesting
Can The New Look Flames Build on Last Season’s Success?

The 2022-23 National Hockey League (NHL) season is right around the corner, with preseason fixtures taking place in the next couple of weeks and the new regular season getting underway on October 7, when the San Jose Sharks take on Nashville Predators in the NHL’s first-ever fixtures in Prague, Czech Republic.
After topping the Pacific Division by seven points over the Edmonton Oilers, Calgary Flames fans have high hopes for the coming campaign. Could this be the season the Flames navigate their way to the Stanley Cup for the first time since 2004?
Darryl Sutter guided the Flames to their eighth divisional championship last season. The Flames finished with 50 victories from 82 games and a +85 goal difference; only the Florida Panthers (+94) enjoyed a better goal difference in the entire league.
The Flames went on to defeat the Dallas Stars 4-3 in the first round of the playoffs but came unstuck against the Edmonton Oilers, losing 4-1 in the second round. Despite the disappointment of the playoffs and having a new look roster with several comings and goings, the best betting sites price the Flames as sixth favourites for Stanley Cup glory this season. Can they live up to that billing and build on last year’s relative success?
A Handful of Key Players Lost
Let us start with the outgoing players from last season’s roster. Johnny Gaudreau and Erik Gudbranson left for the Colombus Blue Jackets, while Calle Jarnkrok now turns out for the Toronto Maple Leafs. In addition, Matthew Tkachuk put pen to paper with the Florida Panthers. Gaudreau is the most significant loss from that quartet, mainly as the winger contributed an impressive 115 regular season points in addition to 14 more during the short playoffs run.
Everyone at the club wanted Gaudreau to stay as a Flame, and the club offered him a monetary package that would have seen him become one of the highest-paid players in the NHL, but the desire to move closer to his family proved too strong, and Gaudreau left for the Colombus Blue Jackets. Gaudreau signed a seven-year deal with $68.25 million.
Tkachuk is another significant blow to the Flames’ roster. He scored 42 goals and 104 points during the successful regular season last year. Tkachuk refused to sign a new long-term deal with the Flames and was traded to the Panthers with a conditional fourth-round in 2025
in exchange for Jonathan Huberdeau, Cole Schwindt, and MacKenzie Weegar.
Major Signings Incoming
Losing the players mentioned above would hurt any roster in the NHL, but the backroom management staff worked hard behind the scenes to ensure the Flames are still a force to be reckoned with in 2022-23.
Bringing in Huberdau is a masterstroke. The 29-year-old left winger is a former third overall draft pick who has played more than 670 professional regular season games and is two goals shy of breaking through the 200 barrier. The 2022 NHL All-Star averages almost a point per game and was exceptional last year with 115 points on the board, thanks to 85 assists.
Former Maples Leafs and Avalanche center Nazem Kadri is another shrewd signing; Kadri was instrumental in the Avalanche’s Stanley Cup victory in 2022.
How Will The Flames Fare in 2022-23?
Everything points towards another exciting season for Flames fans. In Jacob Markstrom and Dan Vlader, the Flames have excellent goaltenders. Markstrom, in particular, is coming off the back of a career-best season. A solid defensive pairing of Noah Hanifin and Rasmus Andersson should see the Flames remain tough to beat; the Flames had the third-best goals against last year.
The probably starting forward line of Huberdeau, Elias Lindholm, and Tyler Toffoli will need to hit the ground running in this new-look Flames team. Still, even the second line of Dylan Dube, Kadri, and Andrew Mangiapane is enough to cause any NHL opponent plenty of problems.
The Flames should reach the playoffs relatively easily; it is anyone’s game from there. Flames fans have every right to be excited about the upcoming season.
Also Interesting
9 Things You Should Know About PK/PD in Drug Research

How do scientists know the right dose of a drug? How long does it stay in the body? And how does it actually work once it gets there?
The answers lie in PK/PD—short for pharmacokinetics and pharmacodynamics—two key concepts that shape how medicines are developed, tested, and refined.
To understand how these two fields guide drug research, it helps to break down what each one actually means.
1. PK/PD Defined in Plain Terms
Pharmacokinetics (PK) tracks what the body does to a drug—how it’s absorbed, distributed, metabolized, and excreted. In contrast, pharmacodynamics (PD) looks at what the drug does to the body—its biological effects and how those effects change with dose or time.
Together, they help researchers fine-tune every stage of drug development—from preclinical studies to dosing decisions.
2. Why Timing Is Everything in PK
Timing isn’t just important; it’s everything. PK shows you how fast a drug gets into the bloodstream, how long it stays active, and when it leaves the body.
That knowledge drives key decisions about medication schedules. Should it be taken once a day or several times? Swallowed or injected? The PK profile helps answer those questions.
PK also makes it possible to track how drug concentrations rise and fall over time, depending on the dose and how the body processes it. Finding the right balance—enough to be effective but not enough to cause harm—is key to designing safe and effective clinical studies.
3. PD Tells You If a Drug Works
Once the drug reaches its target, PD shows what kind of response it triggers in the body. Does it bind to the right receptor? Block a harmful process? PD helps you measure those effects and determine if the drug is doing what it’s supposed to do.
PD data also helps identify when that response starts to fade or becomes too strong. It’s useful for assessing if the drug’s action is strong enough, lasts long enough, and stays within a safe range.
4. PK/PD Models Guide Early Decisions
Before human trials begin, PK/PD modeling is used to predict how a drug might behave in the body. It often relies on preclinical data from animal studies and can simulate a variety of conditions, including how a drug may act in individuals with critical illness.
To use these tools effectively, researchers often consult expert-developed resources that cover essential PK/PD modeling techniques, from foundational principles to advanced applications.
With strong modeling skills, it becomes easier to identify potential issues early, optimize clinical study design, and reduce trial-and-error. This leads to more focused, efficient early-phase research.
5. Animal Data Isn’t Enough
Animal studies provide an important starting point in drug research. They can reveal how a compound behaves and highlight possible risks, like toxicity or poor absorption. But since animals and humans process drugs differently, their results don’t always translate directly.
This is where PK/PD analysis becomes critical. It helps adjust and interpret preclinical findings in a way that’s relevant to human biology. Accurate bioanalytical methods are also needed to track how drugs move through different systems. Without that, early signals could be
misleading.
6. PK/PD Supports Personalized Treatment
People vary in how they respond to medications. A dose that’s right for one person might be too strong—or too weak—for someone else. PK/PD allows for adjustments based on individual factors like age, weight, liver or kidney function, genetics, and other medications.
This kind of personalization improves safety and effectiveness, and it’s becoming an increasingly common goal in clinical pharmacology.
7. Regulatory Agencies Want PK/PD
PK/PD data has become a core part of regulatory review. Agencies like the Food and Drug Administration (FDA) and other regulatory authorities around the world look for this information in drug submissions. It helps explain how a drug works, how its dosage was chosen, and how
safe it appears to be.
This data also supports study design, safety assessments, and the information included on the final drug label. Submissions without it are more likely to face questions, delays, or rejections.
8. PK/PD Helps Uncover Safety Issues
While PK/PD is often associated with measuring effectiveness, it also plays a significant role in identifying safety concerns. It can reveal issues like drug accumulation, interactions with other medications, or delayed side effects.
By connecting drug exposure to those risks, adjustments can be made early, well before the drug reaches a broader population. That leads to safer trials and better long-term outcomes.
9. PK/PD Keeps Evolving
The field of PK/PD is advancing quickly. Better tools and smarter technology are changing how drug behavior is modeled and understood. Machine learning, big data, and improved bioanalytical methods are making it easier to anticipate how drugs will perform under real-world
conditions.
These advances support more reliable predictions and allow teams to adapt faster, either during early testing or when refining late-stage development plans.
Final Thoughts
PK/PD may seem technical at first, but its value is hard to miss. It plays a critical role in making sure new drugs are safe, effective, and precisely delivered. Understanding how these principles guide drug research offers a clearer view of the science behind the medicines we depend on.
Also Interesting
Endorphina Slots: High-Quality Games Now at Zoome Casino Canada

If you’re looking for a provider that blends striking visuals, solid math models, and engaging themes, Endorphina slots are a must-try. Now featured at Zoome casino, Endorphina is quickly becoming a favourite among Canadian players who enjoy well-balanced volatility and great return potential.
From classic fruit machines to themed adventures with expanding wilds, Endorphina in casino environments offers reliable entertainment and serious payout opportunities. But what makes these games stand out? Let’s break down the key features, winning potential, and why you should play Endorphina games at Zoome.
Who Is Endorphina?
Endorphina is a leading game provider based in Prague, with over a decade of experience in developing online slots for regulated markets. The company is known for its well-polished video slots that balance engaging storylines with player-friendly mechanics. Their catalogue includes over 100 titles, with new releases launched regularly.
In Canada, Endorphina slots are now widely accessible through Zoome casino, one of the country’s fastest-growing platforms with a large game library and crypto-friendly payments.
Popular Endorphina Slots You Can Try at Zoome
Once you complete your zoome casino login, head over to the Endorphina slots section to discover a curated list of titles. Here are some fan favourites:
1. Hell Hot 100
● RTP (Return to Player): 96.07%
● Volatility: Medium
● Max Win: 1,000x
● Type: Classic fruit slot with a hot twist
● Why Play: Simple gameplay, blazing fast spins, and high hit frequency
2. Chance Machine 100
● RTP: 96.00%
● Volatility: Low to Medium
● Max Win: 5,000x
● Features: Expanding wilds, stacked symbols
● Why Play: Perfect for casual players who want frequent wins
3. Book of Santa
● RTP: 96.00%
● Volatility: High
● Max Win: 5,500x
● Features: Free spins with expanding symbols
● Why Play: A seasonal slot that pays like a timeless classic
4. Tribe
● RTP: 96.00%
● Volatility: Medium to High
● Max Win: 3,000x
● Special Feature: Free spins with progressive multipliers
● Why Play: Visually beautiful with strong payout structure
All endorphina games are built with HTML5, ensuring smooth play on desktop and mobile without requiring downloads.
Are There Endorphina Free Slots?
Yes! Endorphina free slots are available for demo play directly on Zoome. This means Canadian players can try out their favourites before making a real-money commitment. Free versions include all the same features, visuals, and mechanics — great for getting familiar with a game’s volatility and bonus structure.
To access, simply log in or click the “Demo” button on any title from the Endorphina section on Zoome.
Zoome Casino Bonuses and Endorphina Integration
Zoome casino offers several bonuses that can be used specifically on Endorphina slots, including:
● Welcome bonuses with free spins on selected Endorphina titles
● Reload bonuses for returning players
● Cashbacks and weekend tournaments featuring endorphina slot themes
● Seasonal campaigns with exclusive zoome casino promo codes
New players should check for a potential zoome no deposit bonus, as it occasionally applies to Endorphina’s most popular games like Book of Santa or Hell Hot 100.
RTP, Win Rate & Performance Metrics
Endorphina designs its games with a balance of fairness and entertainment. Here’s a general breakdown:
Metric Range/Typical Value
RTP 96.00% – 96.07%
Average Hit Frequency ~1 in 4 spins
Max Exposure (Base Game) 1,000x to 5,500x
Bonus Trigger Frequency 1 in 120–150 spins (approx.)
Average Session Duration 15–25 mins (based on volatility)
These stats make Endorphina in casino environments appealing to both casual players and slot grinders who understand variance and bankroll management.
Play Anywhere, Anytime
Zoome supports mobile-first gameplay. Every endorphina slot loads seamlessly on iOS and Android without needing an app. With fast servers, secure encryption, and a clean layout, spinning is quick, intuitive, and glitch-free.
Whether you’re chasing a bonus round or enjoying a few free spins on your lunch break, Zoome makes the experience smooth and hassle-free.
Final Thoughts
With its mix of quality graphics, strong RTP, and easy bonus access, Endorphina slots are a solid choice for Canadian players. Whether you’re trying endorphina free slots in demo mode or diving into real-money play via zoome casino login, there’s a title to suit your style.
From well-known hits like Hell Hot 100 to sleeper favourites like Tribe, this provider continues to prove why Endorphina in casino settings is a winning combination. And with regular zoome casino promo code campaigns and potential zoome no deposit bonus access, it’s the perfect time to start spinning.
Ready to explore the full lineup? Visit Zoome and see what Endorphina has to offer — your next big win could be one spin away.
-
COVID-1910 hours ago
FDA requires new warning on mRNA COVID shots due to heart damage in young men
-
Business8 hours ago
Carney’s new agenda faces old Canadian problems
-
Indigenous9 hours ago
Internal emails show Canadian gov’t doubted ‘mass graves’ narrative but went along with it
-
Daily Caller5 hours ago
Blackouts Coming If America Continues With Biden-Era Green Frenzy, Trump Admin Warns
-
Bruce Dowbiggin11 hours ago
Eau Canada! Join Us In An Inclusive New National Anthem
-
Alberta2 days ago
Alberta school boards required to meet new standards for school library materials with regard to sexual content
-
Business2 days ago
UN’s ‘Plastics Treaty’ Sports A Junk Science Wrapper
-
Environment2 days ago
EPA releases report on chemtrails, climate manipulation